Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

ArisGlobal Expert Shares How Regulatory Affairs Needs to Adapt to Transformation Change

The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.